Published in Int J Colorectal Dis on June 01, 1988
Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg (2002) 2.89
The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg (2005) 2.03
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging (2007) 1.81
Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment. Ann Surg Oncol (2015) 1.69
The use of indocyanine green fluorescence to assess anastomotic perfusion during robotic assisted laparoscopic rectal surgery. Surg Endosc (2013) 1.42
Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis (2011) 1.35
Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg (2007) 1.20
MRI in T staging of rectal cancer: How effective is it? Indian J Radiol Imaging (2010) 1.16
Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategies. Ann Surg Oncol (2011) 1.08
Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis (2004) 0.99
MRI staging of low rectal cancer. Eur Radiol (2008) 0.94
Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy. Eur J Nucl Med Mol Imaging (2013) 0.91
The accuracy of Multi-detector row CT for the assessment of tumor invasion of the mesorectal fascia in primary rectal cancer. Abdom Imaging (2008) 0.91
Extralevator versus standard abdominoperineal excision for rectal cancer. Tech Coloproctol (2014) 0.90
Distribution of mesorectal lymph nodes in rectal cancer: in vivo MR imaging compared with histopathological examination. Initial observations. Eur Radiol (2005) 0.89
Rectal cancer: how accurate can imaging predict the T stage and the circumferential resection margin? Int J Colorectal Dis (2003) 0.89
The mesorectum: morphometric assessment with magnetic resonance imaging. Eur Radiol (2005) 0.89
Review of histopathological and molecular prognostic features in colorectal cancer. Cancers (Basel) (2011) 0.85
Techniques in total mesorectal excision surgery. Clin Colon Rectal Surg (2015) 0.85
The Relationship Between MR Demonstration of Extramural Venous Invasion and Nodal Disease in Rectal Cancer. Clin Med Oncol (2008) 0.84
The importance of rectal cancer MRI protocols on interpretation accuracy. World J Surg Oncol (2008) 0.83
Total mesorectal excision for rectal cancer in an unselected population: quality assessment in a low volume center. Int J Colorectal Dis (2009) 0.83
Multidisciplinary discussion and management of rectal cancer: a population-based study. World J Surg (2011) 0.83
Rectal cancer staging: focus on the prognostic significance of the findings described by high-resolution magnetic resonance imaging. Cancer Imaging (2013) 0.82
Microscopic spread of low rectal cancer in regions of mesorectum: pathologic assessment with whole-mount sections. World J Gastroenterol (2004) 0.82
Close distal margins do not increase rectal cancer recurrence after sphincter-saving surgery without neoadjuvant therapy. Int J Colorectal Dis (2012) 0.82
Preoperative chemoradiotherapy in locally advanced rectal cancer: correlation of a gene expression-based response signature with recurrence. Cancer Genet Cytogenet (2009) 0.81
Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases. Radiat Oncol (2011) 0.81
Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer. Int J Colorectal Dis (2009) 0.80
Magnetic resonance imaging (MRI)-based indication for neoadjuvant treatment of rectal carcinoma and the surrogate endpoint CRM status. Int J Colorectal Dis (2008) 0.80
Surgical treatment for rectal cancer: an international perspective on what the medical gastroenterologist needs to know. World J Gastroenterol (2008) 0.80
Significance of mesorectal volume in staging of rectal cancer with magnetic resonance imaging and the assessment of involvement of the mesorectal fascia. Eur Radiol (2006) 0.79
Anus-preserving rectectomy via telescopic colorectal mucosal anastomosis for low rectal cancer: experience from a Chinese cohort. World J Gastroenterol (2013) 0.79
Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer. J Korean Surg Soc (2012) 0.79
Real-time optical diagnosis for surgical margin in low rectal cancer using multiphoton microscopy. Surg Endosc (2013) 0.79
An assessment of the anatomical relationship between the pelvic plexus and the rectal wall to determine the indications for its preservation in surgery for rectal cancer. Surg Today (1997) 0.77
Predictors of circumferential resection margin involvement in surgically resected rectal cancer: A retrospective review of 23,464 patients in the US National Cancer Database. Int J Surg (2016) 0.76
Two-dimensional assessment of submillimeter cancer-free margin area in colorectal liver metastases. Medicine (Baltimore) (2016) 0.75
Rectal cancer staging: Multidetector-row computed tomography diagnostic accuracy in assessment of mesorectal fascia invasion. World J Gastroenterol (2016) 0.75
Sparing Sphincters and Laparoscopic Resection Improve Survival by Optimizing the Circumferential Resection Margin in Rectal Cancer Patients. Medicine (Baltimore) (2016) 0.75
Training in laparoscopic colorectal surgery - experience of training in a specialist unit. Ann R Coll Surg Engl (2010) 0.75
Protocol for a multicentre randomised feasibility trial evaluating early Surgery Alone In LOw Rectal cancer (SAILOR). BMJ Open (2016) 0.75
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis. Lancet (1984) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52
Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis. J Clin Pathol (1998) 1.51
Early diagnosis and prevention of sporadic colorectal cancer. Endoscopy (2001) 1.51
Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology (2001) 1.50
The gastric transitional zones: neglected links between gastroduodenal pathology and helicobacter ecology. Gastroenterology (1999) 1.47
The appendix as a 'skip lesion' in ulcerative colitis. Histopathology (1990) 1.46
Assessment of microsatellite alterations in young patients with gastric adenocarcinoma. Cancer (1997) 1.45
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45
Anaplastic gastric adenocarcinoma with extensive neutrophilic infiltration. Histopathology (1998) 1.44
Vasculitis in ileocaecal tuberculosis: similarities to Crohn's disease. Histopathology (1992) 1.43
Helicobacter pylori and recurrent ulceration after highly selective vagotomy. Eur J Gastroenterol Hepatol (1995) 1.42
Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol (1995) 1.42
Progressive vaccinia complicating lymphosarcoma. J Pathol (1970) 1.41
Fatal accidental ingestion of Clinitest in adult. J R Soc Med (1984) 1.39
DNA aneuploidy in ulcerative colitis. Gut (1986) 1.38
ACP Broadsheet 133: November 1992. Gross examination of the stomach. J Clin Pathol (1992) 1.38
Significance of circumferential resection margin involvement after oesophagectomy for cancer. Br J Surg (1993) 1.38
Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut (1980) 1.37
Adhesion molecules in inflammatory bowel disease. Gut (1995) 1.36
Reflux gastritis in the intact stomach. J Clin Pathol (1990) 1.35
Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer (1985) 1.34
Effect of eradication of Helicobacter pylori on gastric juice ascorbic acid concentrations. Gut (1993) 1.32
DNA aneuploidy in colorectal adenomas. Br J Cancer (1986) 1.32
Ten year follow up of ulcerative colitis patients with and without low grade dysplasia. Gut (2003) 1.32
Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: a comparison between linear measurement, stereology, and computer aided microscopy. J Clin Pathol (1985) 1.30
Assessment of dysplasia in colorectal adenomas: an observer variation and morphometric study. J Clin Pathol (1985) 1.29
Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease. Gut (1983) 1.28
Increased expression of IL-10 and IL-12 (p40) mRNA in Helicobacter pylori infected gastric mucosa: relation to bacterial cag status and peptic ulceration. J Clin Pathol (1999) 1.28
Quantitation of intraepithelial lymphocytes in human duodenum: what is normal? J Clin Pathol (2002) 1.26
Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology (1994) 1.26
Small bowel haemangioma with local lymph node involvement presenting as intussusception. J Clin Pathol (2000) 1.24
Actinomycosis complicating chronic diverticulitis of the sigmoid colon: a missed association? Postgrad Med J (1992) 1.20
The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology (1986) 1.18
Clinical and histological associations of cagA and vacA genotypes in Helicobacter pylori gastritis. J Clin Pathol (1998) 1.17
The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis. Infect Immun (1997) 1.16
Post-irradiation somatic mutation and clonal stabilisation time in the human colon. Gut (1996) 1.13
Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma in an animal model of 'Helicobacter heilmannii' infection. J Pathol (2004) 1.13
Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter (2000) 1.12
Staphylococcal enterocolitis and inflammatory bowel disease. J Clin Pathol (1980) 1.11
The efficacy of tobramycin in the treatment of ulcerative colitis. Aliment Pharmacol Ther (1990) 1.10
Low-grade dysplasia in Barrett's esophagus has a high risk of progression. Endoscopy (2007) 1.09
Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol (1994) 1.09
Pattern of expression of c-erbB-2 oncoprotein in human fetuses. Br J Cancer (1989) 1.08
Feasibility of family based screening for colorectal neoplasia: experience in one general surgical practice. Gut (1993) 1.07
Screening by colonoscopy for colonic epithelial dysplasia in inflammatory bowel disease. Gut (1987) 1.06
Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer? Br J Cancer (1986) 1.06
Colonoscopy and the detection of dysplasia in patients with longstanding ulcerative colitis. Lancet (1980) 1.06
Rectal biopsy for Hirschsprung's disease: what is the optimum method? Pediatr Surg Int (1998) 1.06